Glucotrack EPS GCTK
Diluted earnings per share by quarter and over the last twelve months, from 2010.
- Last 12 months, to Jun 30, 2026
- n/m
- a quarter missing
- Latest quarter, Q2 FY26
- $11.40
- −92% on a year earlier
- Fiscal year 2023
- −$63.00
Glucotrack's twelve-month earnings per share can't be added up yet: a quarter of its results is missing from our data.
In its latest quarter, Q2 FY26, it was $11.40, down 92% on the same quarter a year before.
Earnings per share over time
Fiscal year by fiscal year
| Fiscal year | EPS | Change |
|---|---|---|
| FY2023 | −$63.00 | n/a |
| FY2021 | −$945.00 | n/a |
| FY2020 | −$315.00 | n/a |
| FY2019 | −$1755.00 | n/a |
| FY2018 | −$195390.00 | n/a |
| FY2017 | −$53235.00 | n/a |
| FY2016 | −$63180.00 | n/a |
| FY2015 | −$67860.00 | −474% |
| FY2014 | $18135.00 | n/a |
| FY2013 | −$117585.00 | n/a |
| FY2012 | −$30420.00 | n/a |
| FY2011 | −$2340.00 | n/a |
Each fiscal year is the twelve months to its fourth quarter.
Quarter by quarter
| Quarter | Ended | EPS | On a year earlier | Last 12 months |
|---|---|---|---|---|
| Q2 FY26 | $11.40 | −92% | n/a | |
| Q1 FY26 | $39.75 | −93% | n/a | |
| Q3 FY25 | $69.60 | −100% | n/a | |
| Q2 FY25 | $144.30 | −99% | n/a | |
| Q1 FY25 | $602.10 | n/a | n/a | |
| Q3 FY24 | $16380.00 | n/a | $21078.00 | |
| Q2 FY24 | $14760.00 | +5974% | $4257.00 | |
| Q1 FY24 | −$10557.00 | n/a | −$10260.00 | |
| Q4 FY23 | $495.00 | n/a | −$63.00 | |
| Q3 FY23 | −$441.00 | n/a | n/a | |
| Q2 FY23 | $243.00 | n/a | n/a | |
| Q1 FY23 | −$360.00 | n/a | n/a |
Against its peers
Companies in Medical - Instruments & Supplies nearest Glucotrack's size, closest first, today.
| Company | EPS, 12 months |
|---|---|
| GCTKGlucotrack | n/m |
| PFSAProfusa | n/m |
| VJETFlyte Aviation | n/m |
| BBLGBone Biologics | −$1.61 |
| IVFINVO Fertility | n/m |
| TNONTenon Medical | −$25.65 |
| XAIRBeyond Air | −$68.40 |
| ADGMAdagio Medical | −$1.43 |
| AMIXAutonomix Medical | n/m |
| NXGLNexgel | −$14.20 |
| BJDXBluejay Diagnostics | −$8.68 |
| Peer median | −$11.44 |
What the EPS figure tells you
Net income divided by diluted shares. The denominator of PE.
One-off charges and gains swing it. The TTM view smooths a single odd quarter.
More on Glucotrack
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.